Otherwise, apoA-I [73] or HDLs [146] isolated from T2DM patients lose their ability to inhibit the release of TNF-α and IL-1β by macrophages after lipopolysaccharide stimulation. Here, APOA1 is linked to type 2 diabetes mellitus.